Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: A phase 1/2a study

Stroke

Volumn 47, Issue 7, 2016, Pages 1817-1824

  Steinberg, Gary K ^a   Kondziolka, Douglas ^b   Wechsler, Lawrence R ^c   Lunsford, L Dade ^c   Coburn, Maria L ^a   Billigen, Julia B ^c   Kim, Anthony S ^d   Johnson, Jeremiah N ^a   Bates, Damien ^e   King, Bill ^f   Case, Casey ^e   McGrogan, Michael ^e   Yankee, Ernest W ^e   Schwartz, Neil E ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SanBio Inc   (United States)

^f Western Statistical Consulting   (United States)

Author keywords

allogeneic transplantation; mesenchymal stromal cells; Notch 1; phase 1 clinical trial; stem cells; stereotactic techniques; stroke

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE;

ADULT; AGED; ARTHRALGIA; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; BRAIN CORTEX; CEREBROVASCULAR ACCIDENT; CONSTIPATION; CONVULSION; DECREASED APPETITE; DEPRESSION; DIARRHEA; DIZZINESS; EUROPEAN STROKE SCALE; FEMALE; FOLLOW UP; FUGL MEYER MOTOR FUNCTION TOTAL SCORE; FUGL MEYER TOTAL SCORE; GLUCOSE BLOOD LEVEL; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; MUSCULOSKELETAL PAIN; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN STUDY; OUTCOME ASSESSMENT; PAIN; PATIENT SAFETY; PNEUMOCEPHALUS; PNEUMONIA; PRIORITY JOURNAL; RANKIN SCALE; RATING SCALE; SEIZURE; SPASTICITY; SUBDURAL HEMATOMA; TRANSIENT ISCHEMIC ATTACK; URINARY TRACT INFECTION; VOMITING; CLINICAL TRIAL; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROCEDURES; STROKE; TREATMENT OUTCOME;

ADULT; AGED; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; STROKE; TREATMENT OUTCOME;

EID: 84973370343     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.116.012995     Document Type: Article

References (40)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation 2012 125 e2 e220. doi: 10.1161/CIR.0b013e31823ac046.
2. Lo AC, Guarino P, Krebs HI, Volpe BT, Bever CT, Duncan PW, Multicenter randomized trial of robot-Assisted rehabilitation for chronic stroke: methods and entry characteristics for VA ROBOTICS. Neurorehabil Neural Repair 2009 23 775 783. doi: 10.1177/1545968309338195.
3. Lemmens R, Steinberg GK, Stem cell therapy for acute cerebral injury: what do we know and what will the future bring? Curr Opin Neurol 2013 26 617 625. doi: 10.1097/WCO.0000000000000023.
4. George P, Steinberg GK, Micieli G, Amantea D, Cell based therapies for stroke. In: Rational Basis for Clinical Translation in Stroke Therapy (Frontiers in Neurotherapeutics Series) 2014 Boca Raton, FL CRC Press 427 445
5. Kondziolka D, Steinberg GK, Wechsler L, Meltzer CC, Elder E, Gebel J, Neurotransplantation for patients with subcortical motor stroke: A phase 2 randomized trial. J Neurosurg 2005 103 38 45. doi: 10.3171/jns.2005.103.1.0038.
6. Rabinovich SS, Seledtsov VI, Banul NV, Poveshchenko OV, Senyukov VV, Astrakov SV, Cell therapy of brain stroke. Bull Exp Biol Med 2005 139 126 128
7. Jeong H, Yim HW, Cho YS, Kim YI, Jeong SN, Kim HB, Efficacy and safety of stem cell therapies for patients with stroke: A systematic review and single arm meta-Analysis. Int J Stem Cells 2014 7 63 69. doi: 10.15283/ijsc.2014.7.2.63.
8. Kalladka D, Sinden J, Pollock K, McLean J, Dunn L, Santosh C, Pilot Investigation of Stem Cells in Stroke (PISCES). A phase 1 trial of CTX0E03 human neural stem cells. Cerebrovasc Dis 2013 35 suppl 3 551. doi: 10.1159/000353129.
9. Prasad K, Sharma A, Garg A, Mohanty S, Bhatnagar S, Johri S, InveST Study Group Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: A multicentric, randomized trial. Stroke 2014 45 3618 3624. doi: 10.1161/STROKEAHA.114.007028.
10. Vu Q, Xie K, Eckert M, Zhao W, Cramer SC, Meta-Analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke. Neurology 2014 82 1277 1286. doi: 10.1212/WNL.0000000000000278.
11. Boncoraglio GB, Bersano A, Candelise L, Reynolds BA, Parati EA, Stem cell transplantation for ischemic stroke. Cochrane Database Syst Rev 2010 8 CD007231. doi: 10.1002/14651858.CD007231.pub2.
12. Dezawa M, Kanno H, Hoshino M, Cho H, Matsumoto N, Itokazu Y, Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 2004 113 1701 1710. doi: 10.1172/JCI20935.
13. Yasuhara T, Matsukawa N, Hara K, Maki M, Ali MM, Yu SJ, Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals. Stem Cells Dev 2009 18 1501 1514. doi: 10.1089/scd.2009.0011.
14. Tate CC, Fonck C, McGrogan M, Case CC, Human mesenchymal stromal cells and their derivative, SB623 cells, rescue neural cells via trophic support following in vitro ischemia. Cell Transplant 2010 19 973 984. doi: 10.3727/096368910X494885.
15. Aizman I, Tate CC, McGrogan M, Case CC, Extracellular matrix produced by bone marrow stromal cells and by their derivative, SB623 cells, supports neural cell growth. J Neurosci Res 2009 87 3198 3206. doi: 10.1002/jnr.22146.
16. Kondziolka D, Steinberg GK, Cullen SB, McGrogan M, Evaluation of surgical techniques for neuronal cell transplantation used in patients with stroke. Cell Transplant 2004 13 749 754
17. Hantson L, De Weerdt W, De Keyser J, Diener HC, Franke C, Palm R, The European Stroke Scale. Stroke 1994 25 2215 2219. doi: 10.1161/01.STR.25.11.2215.
18. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Measurements of acute cerebral infarction: A clinical examination scale. Stroke 1989 20 864 870
19. Goldstein LB, Bertels C, Davis JN, Interrater reliability of the NIH stroke scale. Arch Neurol 1989 46 660 662
20. Rankin J, Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J 1957 2 200 215
21. Bonita R, Beaglehole R, Recovery of motor function after stroke. Stroke 1988 19 1497 1500
22. Fugl-Meyer AR, Jääskö L, Leyman I, Olsson S, Steglind S, The post-stroke hemiplegic patient. 1. A method for evaluation of physical performance. Scand J Rehabil Med 1975 7 13 31
23. Sanford J, Moreland J, Swanson LR, Stratford PW, Gowland C, Reliability of the Fugl-Meyer assessment for testing motor performance in patients following stroke. Phys Ther 1993 73 447 454
24. Gladstone DJ, Danells CJ, Black SE, The fugl-meyer assessment of motor recovery after stroke: A critical review of its measurement properties. Neurorehabil Neural Repair 2002 16 232 240
25. Tajiri N, Kaneko Y, Shinozuka K, Ishikawa H, Yankee E, McGrogan M, Stem cell recruitment of newly formed host cells via a successful seduction? Filling the gap between neurogenic niche and injured brain site. PLoS One 2013 8 e74857. doi: 10.1371/journal.pone.0074857.
26. Feys HM, De Weerdt WJ, Selz BE, Cox Steck GA, Spichiger R, Vereeck LE, Effect of a therapeutic intervention for the hemiplegic upper limb in the acute phase after stroke: A single-blind, randomized, controlled multicenter trial. Stroke 1998 29 785 792
27. van der Lee JH, Beckerman H, Lankhorst GJ, Bouter LM, The responsiveness of the Action Research Arm test and the Fugl-Meyer Assessment scale in chronic stroke patients. J Rehabil Med 2001 33 110 113
28. Page SJ, Levine P, Khoury JC, Modified constraint-induced therapy combined with mental practice: thinking through better motor outcomes. Stroke 2009 40 551 554. doi: 10.1161/STROKEAHA.108.528760.
29. van der Lee JH, Wagenaar RC, Lankhorst GJ, Vogelaar TW, Devillé WL, Bouter LM, Forced use of the upper extremity in chronic stroke patients: results from a single-blind randomized clinical trial. Stroke 1999 30 2369 2375
30. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, MR CLEAN Investigators A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015 372 11 20. doi: 10.1056/NEJMoa1411587.
31. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, EXTEND-IA Investigators Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015 372 1009 1018. doi: 10.1056/NEJMoa1414792.
32. Sullivan KJ, Tilson JK, Cen SY, Rose DK, Hershberg J, Correa A, Fugl-Meyer assessment of sensorimotor function after stroke: standardized training procedure for clinical practice and clinical trials. Stroke 2011 42 427 432. doi: 10.1161/STROKEAHA.110.592766.
33. Duncan PW, Propst M, Nelson SG, Reliability of the Fugl-Meyer assessment of sensorimotor recovery following cerebrovascular accident. Phys Ther 1983 63 1606 1610
34. Balu S, Differences in psychometric properties, cut-off scores, and outcomes between the Barthel Index and Modified Rankin Scale in pharmacotherapy-based stroke trials: systematic literature review. Curr Med Res Opin 2009 25 1329 1341. doi: 10.1185/03007990902875877.
35. Zhao H, Collier JM, Quah DM, Purvis T, Bernhardt J, The modified Rankin Scale in acute stroke has good inter-rater-reliability but questionable validity. Cerebrovasc Dis 2010 29 188 193. doi: 10.1159/000267278.
36. Duncan PW, Goldstein LB, Matchar D, Divine GW, Feussner J, Measurement of motor recovery after stroke. Outcome assessment and sample size requirements. Stroke 1992 23 1084 1089
37. Duncan PW, Goldstein LB, Horner RD, Landsman PB, Samsa GP, Matchar DB, Similar motor recovery of upper and lower extremities after stroke. Stroke 1994 25 1181 1188
38. Hendricks HT, van Limbeek J, Geurts AC, Zwarts MJ, Motor recovery after stroke: A systematic review of the literature. Arch Phys Med Rehabil 2002 83 1629 1637
39. Dao MA, Tate CC, Aizman I, McGrogan M, Case CC, Comparing the immunosuppressive potency of naïve marrow stromal cells and Notch-Transfected marrow stromal cells. J Neuroinflammation 2011 8 133. doi: 10.1186/1742-2094-8-133.
40. Dao M, Tate CC, McGrogan M, Case CC, Comparing the angiogenic potency of naïve marrow stromal cells and Notch-Transfected marrow stromal cells. J Transl Med 2013 11 81. doi: 10.1186/1479-5876-11-81.